TOLEDO, Ohio–(BUSINESS WIRE)–#clinicalresearch—NAMSA®,
the world’s only Medical Research Organization (MRO) that accelerates
medical device development through integrated laboratory testing,
clinical research and regulatory consulting services is pleased to
announce the launch of its new online development application, the NAMSA
Biocompatibility Strategy Navigator.
This first-of-a-kind web-based resource assists device manufacturers to
simplify the process of identifying the correct biological
endpoint assessments for intended global regulatory submission
pathways. Utilizing the most up-to-date regulatory requirements to
determine strategic results, the Biocompatibility Strategy Navigator
provides instant recommendations to assist manufacturers to cost-effectively
streamline development initiatives.
“We are extremely pleased to offer the industry’s first online solution
designed to provide medical device organizations with unprecedented,
customized access to the biological tests required for regulatory
approval. This novel application is the only resource available in the
marketplace with no-cost, open access that delivers strategic
recommendations in four simple steps,” commented Jean-Pierre Boutrand,
Vice President of Global Laboratory Services, NAMSA.
The medical device industry’s definitive resource for laboratory
testing for over 50 years, NAMSA offers clients world-class programs
that fast-track development efforts and deliver cost-efficient
development solutions. To date, NAMSA has helped thousands of clients
ensure that their devices enter the international marketplace in the
most safe and efficacious manner possible. NAMSA is proud to continue
its reputation as the premier industry partner for toxicology,
microbiology, chemistry and biocompatibility testing services.
Boutrand concluded, “We are confident that this new application will
serve as a valuable resource for global manufacturers as we work
together to bring life-saving medical technologies to the market in
the most efficient manner possible.”
To access NAMSA’s Biocompatibility Strategy Navigator, please visit: namsa.com/biocompatibility-strategy-navigator.
Clients may also meet with NAMSA’s medical device development experts
on-site at the following upcoming events: https://www.namsa.com/resources/events/.
a Medical Research Organization (MRO), accelerating medical device
product development through integrated laboratory, clinical and
consulting services. Driven by our regulatory expertise, NAMSA’s MRO®
Approach plays an important role in translational research, applying a
unique combination of disciplines – consulting, regulatory, preclinical,
toxicology, microbiology, chemistry, clinical and quality – to move
clients’ products through the development process, and continue to
provide support through commercialization to post-market requirements
anywhere in the world.
NAMSA operates 13 offices throughout North America, Europe, the Middle
East and Asia, and employs over 1,000 highly-experienced laboratory,
clinical and consulting Associates.
Leah Davidson, MA, MBA, 612-615-6985